CompoAtlas

Extraits std. 5% isoflavones de soya, 650 mg

Natural health product licensed in Canada

Licence holder
Les Entreprises Gamma Force Inc.
NPN or DIN-HM
80019376
Status
Inactive licence
Licence date
8 June 2010
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Glycine max

Source : Fève de soja

Potency : 22 mg ÉAI Isoflavones totaux

650 mgNot calculated
Glycine max

Source : Fève de soja

Potency : 5 mg ÉAI Génistéine/Génistine

Not specifiedNot calculated

Non-medicinal ingredients

Hydroxypropylméthylcellulose, Cellulose, microcristalline, Stéarate de magnésium, silice

PopulationAgeQuantity per servingFrequency
Femmes ménopausées et en postménopauseNot specified3 Capsule1 day
FemmesNot specified4 Capsule1 day

Uses authorised in Canada

Pourrait réduire les symptômes graves et fréquents liés à la ménopause (tels que les bouffées de chaleur et/ou les sueurs noturnes). Combiné à un apport suffisant de calcium et de vitamine D, aide à réduire la perte de la densité minérale osseuse (DMO) chez les femmes en postmémopause.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80019376

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Glycine max
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line